We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VAXRABEO Sanofi-Aventis Australia Pty Ltd
Product name
VAXRABEO
Sponsor
Accepted date
Nov-2025
Active ingredients
Rabies virus
Proposed indication
VaxRabeo is a vaccine proposed for rabies prevention, both before someone is exposed to the virus or after they might have been exposed. It is suitable for people of all ages.
VaxRabeo should be used in accordance with local official recommendations.
VaxRabeo should be used in accordance with local official recommendations.
Application type
A (new medicine)
Publication date
Nov-2025